his.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Regulation of 'stemness' and stem cell differentiation by microRNAs
Cellartis AB, Arvid Wallgrens Backe 20, SE-413 46 Göteborg, Sweden.
Högskolan i Skövde, Forskningscentrum för Systembiologi. Högskolan i Skövde, Institutionen för vård och natur.
Cellartis AB, Arvid Wallgrens Backe 20, SE-413 46 Göteborg, Sweden.
Högskolan i Skövde, Forskningscentrum för Systembiologi. Högskolan i Skövde, Institutionen för vård och natur.
2009 (engelsk)Inngår i: IDrugs. The Investigational Drugs Journal, ISSN 1369-7056, E-ISSN 2040-3410, Vol. 12, nr 8, s. 492-496Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Pluripotency and cellular differentiation are intricate biological processes that are coordinately regulated by a complex set of factors and epigenetic regulators. Human pluripotent stem cell lines can be generated from surplus fertilized eggs or, as demonstrated more recently, from the reprogramming of somatic cells. Standardized culture conditions for the long-term maintenance and propagation of undifferentiated human pluripotent stem cells have also been developed. An objective of current research is to increase the understanding of the molecular mechanisms that regulate stem cell differentiation. The differentiation of human pluripotent stem cells may enable the generation of large quantities of specialized cells that can be used as in vitro tools for drug development, as well as for future applications in regenerative medicine. However, most of the currently used differentiation protocols yield inefficient stem cell quantities and low purity of the final cell preparations. The discovery of microRNAs (miRNAs) and their role as important transcriptional regulators may provide a new means of manipulating stem cell fate. This article provides an overview of some recent advancements made in the fields of both stem cell biology and miRNA.

sted, utgiver, år, opplag, sider
BioMed Central, 2009. Vol. 12, nr 8, s. 492-496
HSV kategori
Forskningsprogram
Naturvetenskap
Identifikatorer
URN: urn:nbn:se:his:diva-3513ISI: 000268223700010PubMedID: 19629883Scopus ID: 2-s2.0-68549118772OAI: oai:DiVA.org:his-3513DiVA, id: diva2:279023
Tilgjengelig fra: 2009-12-01 Laget: 2009-12-01 Sist oppdatert: 2017-12-12bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

PubMedScopushttp://www.biomedcentral.com/render/render.asp?arx_id=cd-1027451&type=pdf&access=denied

Personposter BETA

Olsson, BjörnSynnergren, Jane

Søk i DiVA

Av forfatter/redaktør
Olsson, BjörnSynnergren, Jane
Av organisasjonen
I samme tidsskrift
IDrugs. The Investigational Drugs Journal

Søk utenfor DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric

pubmed
urn-nbn
Totalt: 906 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf